BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu C, Huang J, Xu W, Guan Y, Ling H, Mi J, Yan H. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient. Academic Radiology 2018;25:904-14. [DOI: 10.1016/j.acra.2017.12.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ormond Filho AG, Carneiro BC, Pastore D, Silva IP, Yamashita SR, Consolo FD, Hungria VTM, Sandes AF, Rizzatti EG, Nico MAC. Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria. RadioGraphics 2019;39:1077-97. [DOI: 10.1148/rg.2019180096] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
2 Lecouvet FE, Vekemans MC, Van Den Berghe T, Verstraete K, Kirchgesner T, Acid S, Malghem J, Wuts J, Hillengass J, Vandecaveye V, Jamar F, Gheysens O, Vande Berg BC. Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT. Skeletal Radiol 2021. [PMID: 34363522 DOI: 10.1007/s00256-021-03841-5] [Reference Citation Analysis]
3 Paternain A, García-Velloso MJ, Rosales JJ, Ezponda A, Soriano I, Elorz M, Rodríguez-Otero P, Aquerreta JD. The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with 18F-FDG PET-CT. Eur J Radiol 2020;133:109403. [PMID: 33202373 DOI: 10.1016/j.ejrad.2020.109403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jamet B, Zamagni E, Nanni C, Bailly C, Carlier T, Touzeau C, Michaud AV, Moreau P, Bodet-Milin C, Kraeber-Bodere F. Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma. Int J Mol Sci 2020;21:E5406. [PMID: 32751375 DOI: 10.3390/ijms21155406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Wang Q, Zhang L, Li S, Sun Z, Wu X, Zhao A, Benkert T, Zhou D, Xue H, Jin Z, Li J. Histogram Analysis Based on Apparent Diffusion Coefficient Maps of Bone Marrow in Multiple Myeloma: An Independent Predictor for High-risk Patients Classified by the Revised International Staging System. Acad Radiol 2021:S1076-6332(21)00318-4. [PMID: 34452820 DOI: 10.1016/j.acra.2021.07.010] [Reference Citation Analysis]
6 Messiou C, Hillengass J, Delorme S, Lecouvet FE, Moulopoulos LA, Collins DJ, Blackledge MD, Abildgaard N, Østergaard B, Schlemmer HP, Landgren O, Asmussen JT, Kaiser MF, Padhani A. Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS). Radiology 2019;291:5-13. [PMID: 30806604 DOI: 10.1148/radiol.2019181949] [Cited by in Crossref: 83] [Cited by in F6Publishing: 84] [Article Influence: 27.7] [Reference Citation Analysis]
7 Yamada A, Araki Y, Tanaka Y, Otsuki S, Yamada A, Moriyama M, Katagiri S, Suguro T, Asano M, Yoshizawa S, Akahane D, Furuya N, Fujimoto H, Okabe S, Gotoh M, Suzuki K, Saito K, Gotoh A. Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study. PLoS One 2021;16:e0253025. [PMID: 34242226 DOI: 10.1371/journal.pone.0253025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Ferrarazzo G, Chiola S, Capitanio S, Donegani MI, Miceli A, Raffa S, Tagliafico AS, Morbelli S, Bauckneht M. Positron Emission Tomography (PET) Imaging of Multiple Myeloma in a Post-Treatment Setting. Diagnostics (Basel) 2021;11:230. [PMID: 33546455 DOI: 10.3390/diagnostics11020230] [Reference Citation Analysis]
9 Ekert K, Hinterleitner C, Baumgartner K, Fritz J, Horger M. Extended Texture Analysis of Non-Enhanced Whole-Body MRI Image Data for Response Assessment in Multiple Myeloma Patients Undergoing Systemic Therapy. Cancers (Basel). 2020;12. [PMID: 32213834 DOI: 10.3390/cancers12030761] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
10 Heidemeier A, Thurner A, Metz C, Pabst T, Heidemeier H, Rasche L, Kortüm KM, Einsele H, Grimm R, Weiland E, Bley TA. Whole-Body MRI with an Ultrahigh b-Value of 2000 s/mm2 Improves the Specificity of Diffusion-Weighted Imaging in Patients with Plasma Cell Dyscrasias. Academic Radiology 2020. [DOI: 10.1016/j.acra.2020.09.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Costachescu D, Ionita I, Borsi EC, Potre O, Potre C, Navolan DB, Blidisel A, Ionita H, Erimescu A, Pop GN, Malita DC. Whole-body diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma. Exp Ther Med 2021;22:827. [PMID: 34149873 DOI: 10.3892/etm.2021.10259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang Y, Xiong X, Fu Z, Dai H, Yao F, Liu D, Deng S, Hu C. Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: A large single-center cohort study. Eur J Radiol 2019;120:108695. [PMID: 31589995 DOI: 10.1016/j.ejrad.2019.108695] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
13 Zhang B, Bian B, Zhao Z, Lin F, Zhu Z, Lou M. Correlations between apparent diffusion coefficient values of WB-DWI and clinical parameters in multiple myeloma. BMC Med Imaging 2021;21:98. [PMID: 34103001 DOI: 10.1186/s12880-021-00631-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]